Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 4/5 core metricsLatest reported annual revenue changed -10.0% from the prior reported annual observation.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Revenue contracted
Latest reported annual revenue changed -10.0% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- 2 filing risk checks flagged
Flagged areas: Solvency & liquidity.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Operating margin improved
Operating margin changed +13.4 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Free cash flow was positive
Latest reported free cash flow was $37M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-10-21
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Consumables$213M70.7%+1.8% yoy
- Delivery Systems$88.1M29.3%-29.8% yoy
Members sum to the consolidated $301M for this period.
- Americas$204M67.8%-6.0% yoy
- EMEA$68.3M22.7%-4.7% yoy
- Asia Pacific$28.5M9.5%-37.6% yoy
Members sum to the consolidated $301M for this period.
- Consumables$53.9M74.7%no prior
- Delivery Systems$18.3M25.3%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,060 US-listed filers · 314 in Healthcare| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $301M | 38thof 3,247 middle third | 49thof 285 middle third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -10.0% | 12thof 3,083 bottom third | 11thof 270 bottom third |
Gross margin gross profit ÷ revenue | 65.3% | 81stof 1,585 top third | 70thof 206 top third |
Operating margin operating income ÷ revenue | -6.9% | 34thof 2,777 middle third | 50thof 274 middle third |
Net margin net income ÷ revenue | -3.2% | 37thof 3,212 middle third | 55thof 284 middle third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | 12.4% | 71stof 2,640 top third | 77thof 256 top third |
Return on equity net income ÷ stockholders' equity (positive equity only) | -15.6% | 30thof 3,520 bottom third | 45thof 286 middle third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 4.9% | 35thof 2,852 middle third | 42ndof 270 middle third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 26 days | 76thof 2,373 top third | 91stof 259 top third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | -7.9% | 65thof 3,845 middle third | 53rdof 299 middle third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | -59.9% | 90thof 3,301 top third | 88thof 261 top third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 31 changed periods, 30 largest shown| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Stockholders' equity StockholdersEquity | balance at 2020-09-30 | $23.5K 10-Q 2020-11-16 | -$22.5M 10-Q 2021-11-12 | -96191.2% | first · latest |
| Net income NetIncomeLoss | fiscal year 2020-12-31 | -$1.11M 10-K 2021-03-18 | -$29.2M 10-K 2023-03-01 | -2525.2% | first · latest · 3 filings carry it |
| Total liabilities Liabilities | balance at 2020-12-31 | $16.9M 10-K 2021-03-18 | $253M 10-K 2022-03-01 | +1398.9% | first · latest · 6 filings carry it |
| Operating income OperatingIncomeLoss | fiscal year 2020-12-31 | -$1.21M 10-K 2021-03-18 | -$17.2M 10-K 2023-03-01 | -1320.5% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2020-12-31 | $5M 10-K 2021-03-18 | -$30.6M 10-K 2024-03-12 | -711.3% | first · latest · 11 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2021-03-31 | -$602K 10-Q 2021-07-01 | $2.38M 10-Q 2022-05-10 | +495.5% | first · latest |
| Operating cash flow NetCashProvidedByUsedInOperatingActivities | quarter 2021-03-31 | -$512K 10-Q 2021-07-01 | $1.26M 10-Q 2022-05-10 | +346.3% | first · latest |
| Net income NetIncomeLoss | quarter 2022-09-30 | $131K 10-Q 2022-11-09 | -$81K 10-Q 2023-11-14 | -161.8% | first · latest |
| Net income NetIncomeLoss | quarter 2021-03-31 | $13.6M 10-Q 2021-07-01 | -$3.27M 10-Q 2022-11-09 | -124.0% | first · latest · 6 filings carry it |
| Total assets Assets | balance at 2020-12-31 | $464M 10-K 2021-03-18 | $223M 10-K 2022-03-01 | -52.0% | first · latest · 6 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2021-03-31 | -$64.9M 10-Q 2021-07-01 | -$33.2M 10-Q 2022-11-09 | +48.9% | first · latest · 6 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2022-06-30 | -$3.41M 10-Q 2022-08-09 | -$5.03M 10-Q 2023-08-09 | -47.3% | first · latest |
| Net income NetIncomeLoss | quarter 2022-06-30 | $7.93M 10-Q 2022-08-09 | $6.32M 10-Q 2023-11-14 | -20.4% | first · latest · 4 filings carry it |
| Net income NetIncomeLoss | quarter 2023-03-31 | -$22.3M 10-Q 2023-05-10 | -$20.3M 10-Q 2024-11-12 | +9.1% | first · latest · 6 filings carry it |
| Operating income OperatingIncomeLoss | fiscal year 2021-12-31 | -$36.6M 10-K 2022-03-01 | -$39.9M 10-K 2024-03-12 | -9.0% | first · latest · 3 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2022-03-31 | -$13M 10-Q 2022-05-10 | -$14M 10-Q 2023-05-10 | -8.1% | first · latest |
| Operating income OperatingIncomeLoss | fiscal year 2022-12-31 | -$24.3M 10-K 2023-03-01 | -$25.8M 10-K 2025-03-12 | -6.4% | first · latest · 3 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2022-09-30 | -$4.14M 10-Q 2022-11-09 | -$4.35M 10-Q 2023-11-14 | -5.1% | first · latest |
| Net income NetIncomeLoss | quarter 2022-03-31 | $32.5M 10-Q 2022-05-10 | $31.5M 10-Q 2023-11-14 | -3.2% | first · latest · 6 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2023-03-31 | $148M 10-Q 2023-05-10 | $152M 10-Q 2024-11-12 | +3.2% | first · latest · 6 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2022-09-30 | $258M 10-Q 2022-11-09 | $251M 10-Q 2023-11-14 | -2.8% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2022-12-31 | $171M 10-K 2023-03-01 | $167M 10-K 2026-03-12 | -2.6% | first · latest · 10 filings carry it |
| Gross profit GrossProfit | quarter 2022-06-30 | $71.7M 10-Q 2022-08-09 | $70M 10-Q 2023-08-09 | -2.3% | first · latest |
| Gross profit GrossProfit | quarter 2022-03-31 | $51.9M 10-Q 2022-05-10 | $50.9M 10-Q 2023-05-10 | -2.0% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2022-06-30 | $352M 10-Q 2022-08-09 | $345M 10-Q 2023-11-14 | -2.0% | first · latest · 4 filings carry it |
| Gross profit GrossProfit | fiscal year 2021-12-31 | $182M 10-K 2022-03-01 | $179M 10-K 2024-03-12 | -1.8% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2022-03-31 | $342M 10-Q 2022-05-10 | $336M 10-Q 2023-11-14 | -1.6% | first · latest · 6 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2021-12-31 | $302M 10-K 2022-03-01 | $298M 10-K 2025-03-12 | -1.4% | first · latest · 10 filings carry it |
| Net income NetIncomeLoss | fiscal year 2021-12-31 | -$375M 10-K 2022-03-01 | -$379M 10-K 2024-03-12 | -1.0% | first · latest · 3 filings carry it |
| Gross profit GrossProfit | fiscal year 2022-12-31 | $250M 10-K 2023-03-01 | $249M 10-K 2025-03-12 | -0.6% | first · latest · 3 filings carry it |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for SKIN yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.